Literature DB >> 6929491

Evidence for four different polymerization sites involved in human fibrin formation.

S A Olexa, A Z Budzynski.   

Abstract

The mechanism of association and the organization of human fibrin were studied by using affinity chromatography. Insolubilized fibrinogen, fibrin monomer, and crosslinked fibrin were used to localize the binding sites on fibrinogen and fibrin derivatives. Four different polymerization sites have been distinguished. A binding site ("a"), available without thrombin action, is present on the fibrinogen fragment D domain. The complementary ("A") is inoperative in fibrinogen and requires thrombin for activation; it is located on the fibrinogen NH2-terminal domain. A third polymerization site ("b") appears to be formed by the alignment of the fragment D domains on two fibrin monomer molecules upon polymerization; this site functions without thrombin mediation and the alignment is stabilized by the Factor XIIIa-catalyzed crosslink bonds. The "b" site is complementary to another thrombin-activated site ("B") on the fibrinogen NH2-terminal domain. The two thrombin activable sites, "A" and "B", are distinguishable, although they are located in the same fibrinogen domain.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6929491      PMCID: PMC348497          DOI: 10.1073/pnas.77.3.1374

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Structural aspects of the fibrinogen to fibrin conversion.

Authors:  R F Doolittle
Journal:  Adv Protein Chem       Date:  1973

2.  High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization.

Authors:  V J Marder; N R Shulman; W R Carroll
Journal:  J Biol Chem       Date:  1969-04-25       Impact factor: 5.157

3.  Structure of plasmic degradation products of human fibrinogen. Fibrinopeptide and polypeptide chain analysis.

Authors:  A Z Budzynski; V J Marder; J R Shainoff
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

4.  A rapid, sensitive, and specific method for the determination of protein in dilute solution.

Authors:  W Schaffner; C Weissmann
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

5.  Evidence for localization of polymerization sites in fibrinogen.

Authors:  B J Kudryk; D Collen; K R Woods; B Blombäck
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

6.  The effect of plasmin on the subunit structure of human fibrin.

Authors:  S V Pizzo; M L Schwartz; R L Hill; P A McKee
Journal:  J Biol Chem       Date:  1973-07-10       Impact factor: 5.157

7.  N-terminal disulphide knot of human fibrinogen.

Authors:  B Blombäck; M Blombäck; A Henschen; B Hessel; S Iwanaga; K R Woods
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

8.  The purification of fibrinogen degradation products by pevikon block electrophoresis.

Authors:  V J Marder; H L James; S Sherry
Journal:  Thromb Diath Haemorrh       Date:  1969-11-15

9.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

10.  Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen?

Authors:  M Blombäck; B Blombäck; E F Mammen; A S Prasad
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

View more
  26 in total

1.  Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin.

Authors:  M W Mosesson; K R Siebenlist; D L Amrani; J P DiOrio
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

2.  Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Authors:  Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

3.  Polymerization of fibrin: Direct observation and quantification of individual B:b knob-hole interactions.

Authors:  Rustem I Litvinov; Oleg V Gorkun; Dennis K Galanakis; Sergiy Yakovlev; Leonid Medved; Henry Shuman; John W Weisel
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

4.  A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa.

Authors:  L Lorand; K N Parameswaran; S N Murthy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

5.  The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro.

Authors:  K P Pratt; H C Côté; D W Chung; R E Stenkamp; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

6.  The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.

Authors:  Masayoshi Souri; Tsukasa Osaki; Akitada Ichinose
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

7.  A recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemia.

Authors:  Trung C Nguyen; Francisca Gushiken; Juliana I Correa; Jing-Fei Dong; Swapan K Dasgupta; Perumal Thiagarajan; Miguel A Cruz
Journal:  Thromb Res       Date:  2015-03-03       Impact factor: 3.944

8.  Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline.

Authors:  E F Plow; G Marguerie
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

9.  Formation of soluble fibrin oligomers in purified systems and in plasma.

Authors:  N Alkjaersig; A P Fletcher
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

10.  Fibrinogen Osaka IV: a congenital dysfibrinogenemia found in a patient originally reported in relation to surgery, now defined to have an A alpha arginine-16 to histidine substitution.

Authors:  K Yamazumi; S Terukina; M Matsuda; J Kanbayashi; M Sakon; T Tsujinaka
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.